Image thumbnail

Bacillus clausii 088AE Joins Canada’s VHP List

Bacillus clausii 088AE Joins Canada’s VHP List

Why It Changes Everything for Pet Supplement Formulators

Pet probiotic shelves are crowded with lookalike formulas. Same species names. Same broad claims. Same positioning. Real differentiation has become harder than ever to prove.

Canada’s Veterinary Health Product (VHP) framework changes that equation.

Health Canada does not hand out VHP recognition lightly. Inclusion requires precise strain identification, documented safety, manufacturing consistency and substantiated claims backed by evidence. It’s a high bar. Most probiotic strains never make it through the process.

Bacillus clausii 088AE (SEBclausii™) did more than qualify. It became the only Bacillus clausii strain listed on Canada’s VHP list for dogs.

For pet supplement brands, that distinction creates immediate competitive separation that no other B. clausii strain can claim.

Why VHP Status Carries Weight

VHP recognition is far more than a regulatory milestone. Retail buyers, veterinarians and pet parents increasingly look for scientific credibility in a market saturated with marketing noise.

VHP-listed ingredients communicate a higher standard from the start. For formulators and brands, the advantages are tangible:

  • Faster internal alignment across regulatory & marketing teams
  • Stronger credibility with veterinary & retail channels
  • Cleaner path through product development
  • Defensible, premium positioning in a crowded market

Consumers may not understand the technical details behind VHP approval, but they understand trust. In a category overflowing with interchangeable probiotics, VHP status creates a clear reason to believe.

Science & Regulatory Strength in One Ingredient

Regulatory positioning matters most when backed by meaningful science.

Human-grade Bacillus clausii 088AE (SEBclausii™) has earned:

  • An FDA GRAS (Generally Recognized as Safe) No Objection letter, making it the only Bacillus clausii strain to receive GRAS recognition from the FDA
  • A Health Canada NPN with approved claims

Scientific backing extends beyond regulatory recognition. Five gold-standard human clinical and in vitro studies published in peer-reviewed journals support claims for gut and immune health.*

Strong regulatory standing paired with published research gives formulators a powerful foundation for product claims, brand storytelling and long-term market positioning.

Built for Real-World Formulation Conditions

Even the strongest science loses value if a probiotic cannot survive manufacturing, shipping and storage.

  1. clausii 088AE delivers where many probiotics fall short.

As a spore-forming probiotic, B. clausii 088AE is naturally protected by a robust endospore that allows it to withstand conditions that often damage conventional probiotics.

Performance advantages include:

  • 98-100% viability across a wide pH range for up to 5 hours*
  • High viability at temperatures up to 90°C for up to 1 hour*
  • Stable CFU counts over 30 months at room temperature (25°C / 60% RH)*
  • No refrigeration needed*

Stability at every stage of the supply chain reduces formulation risk, minimizes potency loss and helps ensure label claim delivery through shelf life.*

For manufacturers, greater resilience means fewer compromises during processing and greater confidence in the finished product.

A Multi-Strain Solution Designed for Companion Animal Health

  1. clausii 088AE also serves as a foundational strain in ProbioSEB CSC3 Pet™, a revolutionary three-strain spore-forming probiotic blend developed specifically for companion animal applications.

The formula combines:

Study results show these strains support:

  • Nutrient digestion & absorption*
  • Healthy gut microbiota balance & diversity*
  • Healthy immune modulation*
  • Inhibition of growth of undesirable gut microorganisms*
  • Resolution of diarrhea*
  • Improved stool consistency*
  • Gut health*

All three strains are non-pathogenic, soil-based (SBO) spore-formers that survive gastrointestinal transit in greater numbers, colonizing in the gut more effectively.*

Beyond survivability, the probiotics in ProbioSEB CSC3 Pet™ produce lactic acid, short-chain fatty acids, digestive enzymes and bacteriocins that support digestive comfort, microbiome balance and immune homeostasis.*

To top it off, both SEBiotic® and SEBtilis™ have also been granted FDA GRAS (Generally Recognized as Safe) No Objection letters and Health Canada NPNs with approved claims, making ProbioSEB CSC3 Pet™ a regulatory powerhouse.

Pet brands looking for a premium turnkey solution gain access to both multi-strain functionality and a highly differentiated regulatory story in a single formulation platform.

Manufacturing Quality Matters Too

Ingredient quality does not stop with the strain itself.

Specialty Enzymes & Probiotics brings more than 45 years of nutraceutical expertise to fermentation, ingredient development and manufacturing. Products are manufactured in NSF GMP, FSSC 22000 and ISO 17025-certified facilities and undergo third-party testing for quality assurance.

  1. clausii 088AE and ProbioSEB CSC3 Pet™ are also certified vegan, gluten-free and kosher, supporting the preferences of many of today’s ingredient-conscious pet parents.

When working with Specialty, brand partners gain more than a raw material supplier. They gain formulation guidance, short lead times and a partner invested in their product’s success.

One Regulatory First, One Potent Blend, Endless Market Potential

Bacillus clausii 088AE stands alone as the only Bacillus clausii strain recognized on Canada’s VHP list for dogs.

ProbioSEB CSC3 Pet™ builds on that distinction with a synergistic, science-backed blend designed for modern companion animal health formulations.

Clinical support. Proven stability. Regulatory credibility. Advanced spore-forming technology. Premium manufacturing standards. Few ingredients can claim one of these advantages. Even fewer combine all of them.

For pet supplement brands competing in an increasingly crowded market, differentiation is no longer optional. It is the foundation of category leadership.

Reach out today to learn more about Bacillus clausii 088AE and ProbioSEB CSC3 Pet™!